This inventor holds 1 USPTO granted patent. Top assignees: The University of New Mexico, University of Michigan. Active years: 2007.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2007
Title: Mei Shi - Innovator in G Protein Coupled Receptor Research
Introduction
Mei Shi is a prominent inventor based in Albuquerque, NM (US). She has made significant contributions to the field of biochemistry, particularly in the study of G protein coupled receptors (GPCRs). Her innovative work has led to advancements in understanding receptor interactions and their implications in drug discovery.
Latest Patents
Mei Shi holds a patent titled "Bead-based detection of ligand-GPCR-G protein complexes." This invention provides a general approach for studying G protein coupled receptors, which can be utilized to define agonists and antagonists, as well as the specificity of receptor coupling to G protein subunits. The methods described in her patent utilize small volumes (microliters) and are compatible with high throughput flow cytometry. Notably, when assays are multiplexed, the specificity of receptor interactions with multiple G proteins can be determined simultaneously. She has 1 patent to her name.
Career Highlights
Throughout her career, Mei Shi has worked at esteemed institutions such as the University of New Mexico and the University of Michigan. Her research has garnered attention for its innovative approaches and practical applications in the field of pharmacology.
Collaborations
Mei Shi has collaborated with notable colleagues, including Tione Buranda and Richard Neubig. These partnerships have further enriched her research and contributed to the advancement of knowledge in GPCR studies.
Conclusion
Mei Shi's contributions to the field of G protein coupled receptors through her innovative patent and collaborative efforts highlight her role as a leading inventor in biochemistry. Her work continues to influence research and development in drug discovery and receptor biology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile